Gilead Says Counterfeiting Network Sold $250 Mln Worth of Its HIV Drugs
Gilead Sciences said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over 2 years by a network of drug distributors and suppliers.